Myriad Genetics, Inc. (MYGN)
3.18
+0.06
(+1.92%)
USD |
NASDAQ |
Aug 27, 16:00
3.175
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Market Cap : 304.01M for Aug. 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 27, 2026 | 304.01M |
| August 26, 2026 | 298.27M |
| August 25, 2026 | 304.96M |
| August 24, 2026 | 291.58M |
| August 21, 2026 | 305.92M |
| August 20, 2026 | 307.83M |
| August 19, 2026 | 304.96M |
| August 18, 2026 | 274.37M |
| August 17, 2026 | 291.58M |
| August 14, 2026 | 289.67M |
| August 13, 2026 | 303.05M |
| August 12, 2026 | 308.79M |
| August 11, 2026 | 307.83M |
| August 10, 2026 | 310.70M |
| August 07, 2026 | 311.66M |
| August 06, 2026 | 304.01M |
| August 05, 2026 | 301.14M |
| August 04, 2026 | 303.05M |
| August 03, 2026 | 288.71M |
| July 31, 2026 | 273.42M |
| July 30, 2026 | 513.37M |
| July 29, 2026 | 481.82M |
| July 28, 2026 | 508.59M |
| July 27, 2026 | 521.02M |
| July 24, 2026 | 529.58M |
| Date | Value |
|---|---|
| July 23, 2026 | 538.08M |
| July 22, 2026 | 534.30M |
| July 21, 2026 | 557.90M |
| July 20, 2026 | 558.85M |
| July 17, 2026 | 583.39M |
| July 16, 2026 | 584.34M |
| July 15, 2026 | 595.66M |
| July 14, 2026 | 570.18M |
| July 13, 2026 | 553.18M |
| July 10, 2026 | 550.35M |
| July 09, 2026 | 575.84M |
| July 08, 2026 | 554.13M |
| July 07, 2026 | 553.18M |
| July 06, 2026 | 569.23M |
| July 02, 2026 | 565.46M |
| July 01, 2026 | 566.40M |
| June 30, 2026 | 539.02M |
| June 29, 2026 | 552.24M |
| June 26, 2026 | 555.07M |
| June 25, 2026 | 512.59M |
| June 24, 2026 | 492.77M |
| June 23, 2026 | 437.07M |
| June 22, 2026 | 424.80M |
| June 18, 2026 | 428.58M |
| June 17, 2026 | 413.47M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Natera, Inc. | 48.64B |
| Sera Prognostics, Inc. | 80.06M |
| BioRestorative Therapies, Inc. | 5.248M |
| CareDx, Inc. | 2.696B |
| Exagen, Inc. | 181.93M |
Market Cap Related Metrics
| PS Ratio | 0.3695 |
| Price to Book Value | 1.000 |
| Price | 3.18 |
| Earnings Yield | -37.69% |